Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
TRIL - Trillium Therapeutics Inc
$14.56
0.00(0.00%)5:00:00 AM 1/15/2021
Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. Its product candidates also include TTI-622 that is in Phase I clinical trial of immunoglobulin G4 SIRPaFc protein; and TTI-10001, a small molecule stimulator of interferon genes agonist that senses cytosolic DNA for promoting tumor immunity, which is in the discovery Phase. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was founded in 2004 is headquartered in Mississauga, Canada.
Stock Chart

Summary:

  • MACD is crossing MACD signal line at 0.2. MACD crossing signal line is bullish signal.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics

Stock news

    01/13/2021TRIL
    3 Top Biotech Picks for January

    Biotech stocks were huge winners for investors last year, with some seeing 1,000% gains. If you're looking for a stock in this sector to add to your portfolio, Amgen (NASDAQ: AMGN), Trillium Therapeutics (NASDAQ: TRIL), and Illumina (NASDAQ: ILMN) are solid biotech choices for this month. Amgen, founded in 1980, is one of the older, larger biotech companies in the world.

    01/12/2021TRIL
    1 Big Reason Trillium Therapeutics Stock's Hot Streak Will Continue in 2021

    When it comes to countering a key trick that cancer plays on the human immune system, this biotech has no equal.

    01/5/2021TRIL
    Companies Like Trillium Therapeutics (TSE:TRIL) Can Afford To Invest In Growth

    Just because a business does not make any money, does not mean that the stock will go down. By way of example, Trillium...

    01/4/2021TRIL
    PIMCO Closed-End Funds Declare Monthly Common Share Distributions

    NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) -- The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a “Fund” and, collectively, the “Funds”) have declared a monthly distribution for each Fund’s common shares as summarized below. The distributions are payable on February 1, 2021 to shareholders of record on January 14, 2021, with an ex-dividend date of January 13, 2021.  Monthly Distribution Per Share FundNYSE SymbolAmountChange From Previous MonthPercentage Change From ...

    01/4/2021TRIL
    The Worst Mistake Trillium Investors Can Make Right Now

    In his book One Up on Wall Street, Peter Lynch says that "selling winners and holding your losers is like cutting the flowers and watering the weeds." That's great advice in some circumstances, but following it might be the worst thing shareholders of Trillium Therapeutics (NASDAQ: TRIL) could do right now.

    01/4/2021TRIL
    My Favorite Biotech Stock for 2021

    Biotechs have consistently dominated the list of best-performing stocks over the past two decades. Which biotech stocks are poised for rocket-like growth in 2021? Here's why I think this small-cap biotech could be a big winner in 2021.

    01/4/2021TRIL
    3 Healthcare Stocks That Could Soar In 2021

    If you're looking for stocks that can deliver outstanding gains in good economic conditions and bad, there are at least three great options for you right now in the healthcare sector. Investors with shares of Trillium Therapeutics (NASDAQ: TRIL), Teladoc Health (NYSE: TDOC), and Nanox (NASDAQ: NNOX) have good reasons to expect big returns this year. Nanox made its stock market debut last August and in the process raised around $190 million to produce Nanox.ARC, a low-cost digital X-ray imaging...

    12/21/2020TRIL
    Is TRIL A Good Stock To Buy According To Hedge Funds?

    Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren’t timid and registered double digit market beating gains. Financials, energy and industrial stocks aren’t doing […]

    12/17/2020TRIL
    Implied Volatility Surging for Trillium (TRIL) Stock Options

    Investors need to pay close attention to Trillium (TRIL) stock based on the movements in the options market lately.

    12/17/2020TRIL
    Could Trillium Fall Below $10 in 2021?

    Small biotech companies have notoriously volatile stocks. It doesn't hurt that every once in a while a company can seem to discover medicinal gold as it parlays a discovery into a blockbuster drug or multibillion-dollar acquisition. Early results from a phase 1 study in January showed the company's two drug candidates, TTI-621 and TTI-622, demonstrated the ability to block the signal that nearly all cancer cells use to cloak themselves from the immune system.